Neuromod Devices Closes €30m Financing

FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval 

COVID and Tinnitus: Florian’s Story

Tinnitus Week 2023 Proudly Sponsored by Lenire

Christy Reynolds: Meet the Neuromod Team

Living with Tinnitus: Two Tinnitus Sufferers. Two Diverse Experiences.

How is Tinnitus Treated? Prof. Hubert Lim Explains

Lenire Proudly Sponsors Outring Tinnitus Podcast

The Results of Lenire’s Second Large Scale Clinical Trial Have Been Published – Here’s Everything You Need To Know

TENT-A1 Trial User Experience Data: Usability of Bimodal Neuromodulation to Treat Tinnitus

Lenire is now available from HØR AS, Norway’s largest private provider of tinnitus care

Clinically proven Lenire tinnitus treatment device now available from The Audiology Clinic in Dublin, Cork, and Kildare

Hola Lenire: Tinnitus Device Now Available in Spain

Real-world evidence demonstrates the safety and efficacy of Lenire device for improving symptoms in tinnitus patients

(Almost) everything you need to know about tinnitus

Three lessons from Neuromod’s Chief Scientific Officer, Professor Hubert Lim’s interview with Dr Ben Thompson

Órla’s Story

Damian’s Lenire Story

Karen’s Lenire Story

Erlandas’ Lenire Story

Telemedicine: A game-changer for tinnitus patients in the COVID age

Neuromod research reveals that more than three in four UK tinnitus sufferers have never received treatment for their condition

Lenire launches across Hungary